IsoPSA: Prostate Cancer Detection
Prostate cancer screening faces challenges with traditional PSA tests, often leading to false positives and unnecessary biopsies. IsoPSA, a next-generation assay, evaluates PSA protein structure to better identify aggressive cancers, helping both patients and clinicians make informed decisions. Clinical studies confirm its accuracy, predictive utility, and long-term reliability.
Read more...